News | Treatment Planning | February 18, 2022

Montérégie Integrated Cancer Center (CICM), which is part of the Charles-Le Moyne hospital in Longueuil in Quebec in Canada, has placed an order for additional RayStation licenses as well as upgrades to the system which includes advanced treatment planning functionality

RaySearch has a strong position in the radiotherapy market in Canada with a market share of approximately 25 percent. Charles-Le Moyne hospital has been a RayStation customer since 2018.

February 18, 2022 — RaySearch has a strong position in the radiotherapy market in Canada with a market share of approximately 25 percent. Charles-Le Moyne hospital has been a RayStation customer since 2018. With the planned expansion, the cancer clinic will now fully replace their former treatment planning system with RayStation for all of their radiation oncology services, which today includes eight linear accelerators. Further, the clinic has added new and advanced technology to the order, including multi-criteria optimization, dose tracking, adaptive planning and TomoTherapy planning.

Johan Löf, founder and CEO, RaySearch, says: “RaySearch is always pleased when a customer has experienced our products and services, and then chooses to expand their utilization based on that success. We appreciate their trust in us, as well as their dedication to their patients, and expect that our excellent relationship with the team at Charles-Le Moyne will continue for many years.”

About Charles-Le Moyne hospital

Cancer treatment at Charles-Le Moyne hospital is provided by the team at Montérégie Integrated Cancer Center (CICM). The CICM is a center of excellence and reference in the fight against cancer recognized as a leader in Montérégie. Each year, the CICM receives some 48,000 visits and the center treats nearly 30 types of cancer.

For more information: www.raysearchlabs.com


Related Content

News | Radiation Therapy

March 28, 2023 — People exposed to low doses of ionizing radiation have an extra, but modest, risk of developing heart ...

Time March 28, 2023
arrow
News | Lung Imaging

March 27, 2023 — On Target Laboratories, Inc., a privately held biotechnology company developing intraoperative ...

Time March 27, 2023
arrow
News | PET Imaging

March 23, 2023 — Nuclidium announced that the Neuroendocrine Tumors Research Foundation (NETRF) has selected the company ...

Time March 24, 2023
arrow
News | Lung Imaging

March 22, 2023 — The Riverain Technologies ClearRead Bone Suppression solution is now available on the Siemens ...

Time March 22, 2023
arrow
News | Quality Assurance (QA)

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery ...

Time March 16, 2023
arrow
News | Lung Imaging

March 15, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time March 15, 2023
arrow
News | Radiation Oncology

March 14, 2023 — Elekta announced that is has signed a joint venture with China National Pharmaceutical Group Co., Ltd. ...

Time March 14, 2023
arrow
News | Digital Pathology

March 13, 2023 — Proscia, a leading provider of digital and computational pathology solutions, today announced that ...

Time March 13, 2023
arrow
Feature | Radiology Business | By Christine Book

With an increasing focus on personalizing the patient experience and enhancing communication between radiologists and ...

Time March 10, 2023
arrow
News | Digital Pathology

March 7, 2023 — Proscia, a leading provider of digital and computational pathology solutions, today announced that ...

Time March 07, 2023
arrow
Subscribe Now